Testicular spermatozoa have statistically significantly lower DNA damage compared with ejaculated spermatozoa in patients with unsuccessful oral antioxidant treatment
To access this article, please choose from the options below
S.I.M. has nothing to disclose. K.J. is a paid consultant for Bayer. J.B.M.M. has nothing to disclose. K.I.C. has nothing to disclose. T.H. has nothing to disclose. K.C.L. is an employee of Bayer Canada.
PII: S0015-0282(08)04551-2
doi:10.1016/j.fertnstert.2008.11.005
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

